This announcement gives a brief overview of World TB Day, which recognizes the collaborative efforts of all countries involved in eliminating TB.
Favorite
2001
This report discusses two cases of latent TB infection in which patients developed severe or fatal hepatitis associated with rifampin-pyrazinamide (RIF-PZA) treatment.
Favorite
2001
This manual presents a role-play-based curriculum on how to conduct a contact investigation for persons with TB. It provides scripts and evaluation forms for each role-play session.
Favorite
2001
This fact sheet discusses the meaning of a negative TB skin test and states that persons with HIV/AIDS may be at risk for false negative results.
Favorite
2001
This fact sheet explains the purpose of the Global Drug Facility (GDF) to expand access to, and availability of, high-quality TB drugs to facilitate DOTS expansion, and to enable governments and nongovernmental organizations (NGOs) to implement effective TB control programs based upon the DOTS stragegy.
Favorite
International Agencies
2001
This prospectus is a culmination of input from Stop TB Partners including representatives from TB high-burden countries, UN agencies, Nongovernmental Organizations (NGOs), and foundations to develop the form, strategies, objectives, and governance of the Global TB Drug Facility (GDF).
Favorite
International Agencies
2001
This report highlights the accomplishments of World TB Day 2001.
Favorite
Community Leaders
2001
This booklet presents the frequent misconceptions and beliefs about TB in relation to HIV/AIDS. The contents are presented in a question and answer format using simple language with some photos from the field. This booklet also serves as a material for community TB training.
Favorite
Community Leaders
2001
This report presents the findings of a short-term study to examine the risk of TB among health care workers. It discusses the possible effects of federal guidelines, responses to resurgent TB, and proposed strategies for eliminating TB in the United States and worldwide.
Favorite
Health Educators/Communicators
Infection Control and Occupational Health Workers
2001
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
Favorite
2001
This report provides findings from a study designed to compare a whole-blood interferon gamma assay, the QuantiFERON-TB test, with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection and to identify factors associated with discordance between the tests.
Favorite
2001
This information packet discusses the use of a clinician-based referral and tracking system for migrant workers with TB. It includes samples of a pocket-sized bilingual (English/Spanish) treatment record for migrant workers.
Favorite
2001
This monograph discusses the history of TB, the search for TB treatment and diagnostic methods, and its resurgence, including the emergence of multiple drug resistant (MDR) strains of TB.
Favorite
2001
These four self-study modules cover public health and public nursing issues, the fundamentals of TB case management, leadership skills of the nurse case manager, and case management of pediatric patients with TB.
Favorite
2001
This report presents information about the Global TB Drug Facility, a program designed to ensure access to and the availability of TB drugs.
Favorite
International Agencies
2001
This fact sheet, available online or via fax only, discusses who should receive treatment, regimen options for HIV-infected persons as well as those not infected, and monitoring.
Favorite
2001
This report outlines a strategy for management of human resources for TB control.
Favorite
2002
This fact sheet includes helpful hints on pediatric medicine administration if a child has difficulty swallowing pills or capsules.
Favorite
Parents/Families
2002
This report summarizes data from the national TB surveillance system for 2000 and compares them with data from 1992 to 1999.
Favorite
2002
This report discusses the burdens of AIDS, malaria, and TB; assesses the tools used to fight them; identifies barriers to success; and provides statistics on deaths caused by these diseases in 2000.
Favorite
International Agencies
Managers and Supervisors
2002